GI
REGN icon

GAMMA Investing’s Regeneron Pharmaceuticals REGN Stock Holding History

GAMMA Investing’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
2,067
-440
-18% -$299K 0.05% 326
2026
Q1 		$1.94M Buy
2,507
+326
+15% +$250K 0.09% 192
2025
Q4 		$1.68M Buy
2,181
+455
+26% +$309K 0.08% 197
2025
Q3 		$970K Buy
1,726
+451
+35% +$255K 0.05% 297
2025
Q2 		$669K Sell
1,275
-11
-0.9% -$6.14K 0.04% 385
2025
Q1 		$816K Buy
1,286
+379
+42% +$261K 0.06% 283
2024
Q4 		$646K Sell
907
-529
-37% -$444K 0.06% 297
2024
Q3 		$1.51M Buy
1,436
+353
+33% +$393K 0.15% 124
2024
Q2 		$1.14M Buy
1,083
+199
+23% +$193K 0.16% 117
2024
Q1 		$851K Buy
884
+154
+21% +$146K 0.17% 102
2023
Q4 		$688K Buy
+730
New +$601K 0.19% 89

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

GAMMA Investing's REGN Position: Q2 2026 in Review

GAMMA Investing reduced its Regeneron Pharmaceuticals (REGN) stake by 18% in Q2 2026, selling an estimated $299K and leaving 2,067 shares worth $1.29M. The position accounts for 0.05% of the portfolio, ranked #326.

GAMMA Investing first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.94M in Q1 2026. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • GAMMA Investing held 2,067 shares of Regeneron Pharmaceuticals worth $1.29M as of Q2 2026.
  • GAMMA Investing sold 440 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $299K.
  • Regeneron Pharmaceuticals made up 0.05% of GAMMA Investing's portfolio in Q2 2026, its #326 holding.
  • GAMMA Investing first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Regeneron Pharmaceuticals position peaked at $1.94M in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.